Cours Puma Biotechnology Inc Nyse
Actions
US74587V1070
Recherche biotechnologique et médicale
CA 2024 * | 219 M 199 M | CA 2025 * | 225 M 204 M | Capitalisation | 248 M 225 M |
---|---|---|---|---|---|
Résultat net 2024 * | 10 M 9,07 M | Résultat net 2025 * | 15 M 13,6 M | VE / CA 2024 * | 1,13 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 1,1 x |
PER 2024 * |
21,2
x | PER 2025 * |
21,1
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 84,6% |
Dernier transcript sur Puma Biotechnology Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/09/10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05/11/18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/03/13 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23/02/18 |
Jay Moyes
BRD | Director/Board Member | 70 | 27/04/12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/09/10 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,03% | 48,16 Md | |
-0,10% | 41,73 Md | |
+43,45% | 41,03 Md | |
-5,26% | 28,77 Md | |
+11,48% | 25,59 Md | |
-22,74% | 18,96 Md | |
+9,06% | 12,92 Md | |
+30,01% | 12,03 Md | |
-1,51% | 11,77 Md |